GR-144043

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGR-144043
Drug Alias NameGR-144043
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoagulation factor inhibitorsPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12Coagulation factor
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxo Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxo Group Ltd
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeN/A
Related LinksN/A